CAN.AX

Healthcare Drug Manufacturers - Specialty & Generic

Cann Group Limited

A$0.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

7.47M

Avg Volume

3.36M

P/E (TTM)

0.23

EPS

A$0.02

52W High

A$0.02

52W Low

A$0.00

Div. Yield

0.0%

Valuation

Forward P/E

0.01

P/B Ratio

0.25

P/S Ratio

0.77

EV/EBITDA

-4.84

EV/Revenue

2.43

Margins

Gross Margin 62.1%

Operating Margin (91.5%)

Net Margin 213.7%

EBITDA Margin (50.2%)

Growth & Returns

Revenue Growth (YoY)

(24.4%)

Return on Equity

157.4%

Return on Assets

(10.2%)

Liquidity & Leverage

Current Ratio

0.98

Quick Ratio

0.22

Debt / Equity

0.57

Total Cash

490,000

Total Debt

16.45M

About

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.